Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
Clinical trial NCT02728947 · COMPLETED
Trial details
- NCT number
- NCT02728947
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2016-08-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.